Rev. Hosp. Niños B.Aires; 60 (268), 2018
Publication year: 2018
Objetivo:
Describir características clínicas, antecedentes de vacunación, recursos médicos utilizados y continuidad del esquema de vacunación de los casos de Episodio de Hipotonía Hiporrespuesta (EHH) que consultaron al Vacunatorio del Hospital de Niños Ricardo Gutiérrez (HNRG).
Materiales y métodos:
Estudio descriptivo de serie de casos. Se incluyeron los niños con diagnóstico de EHH, según los Criterios de Brighton, que consultaron entre Enero 2010 y Agosto 2017.
Resultados:
Se registraron 14 casos, 1 se descartó por datos insuficientes (n= 13). La media de
edad fue 5 meses, sin predominio de sexo. Diez casos se presentaron luego de la 1° dosis y todos
antes de las 24hs. Recibieron quíntuple celular 12 pacientes, hexavalente 1; recibieron otras vacunas
11 casos. Síntomas concomitantes más frecuentes:
fiebre e irritabilidad. Realizaron consulta médica
12 y se internaron 9. Doce tuvieron recuperación total, de 1 no hay datos. Ocho continuaron el esquema con vacuna acelular, uno con celular y ninguno presentó complicaciones.
Conclusiones:
Todos presentaron el EHH dentro de las 24hs post vacunación con componente
pertussis, con recuperación completa. La mayoría luego de la primera dosis. Más del 80% requirió
consulta médica y casi el 70% internación. La continuidad del esquema no se asoció con complicaciones
Objective:
To describe the clinical manifestations, vaccination history, medical resources used
and the continuity of the vaccination schedule in all the cases of hypotonic-hyporesponsive episodes (HHE) seen in the immunization center of Ricardo Gutierrez Children´s Hospital.
Materials and methods:
Descriptive study of a retrospective case series. All children diagnosed with HHE according to the Brighton Criteria, who were seen between January 2010 and August 2017, were included.
Results:
There were 14 cases, one of which was dismissed due to insufficient data (n= 13). The
mean age was 5 months, with no predominance of sex. Ten of the episodes occurred after the 1st dose
and all of them within 24 hs. Twelve patients received pentavalent whole-cell vaccines, one received
the hexavalent vaccine and eleven received other vaccines. The most frequent concomitant symptoms were fever and irritability. Twelve required medical consultation and nine, hospitalization.
Evolution:
12 recovered completely and data were missing from 1. Eight of the patients who were
followed up continued with acellular vaccines, one with pentavalent whole-cell vaccine. None presented complications.
Conclusions:
All patients presented the HHE within 24 hours after the administration of pertussis component vaccines, recovering completely HHE has been observed mainly after the first dose More
than 80% required medical consultation and almost 70%, hospitalization. The continuity of the schedule
was not associated with complications